Advance Search
LI Yunling, ZHANG Yazhou, ZHANG Yunfang, TONG Jing, WANG Weiwei. Effect of oral probiotics on intestinal microecology in patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2024, 28(9): 73-77. DOI: 10.7619/jcmp.20233646
Citation: LI Yunling, ZHANG Yazhou, ZHANG Yunfang, TONG Jing, WANG Weiwei. Effect of oral probiotics on intestinal microecology in patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2024, 28(9): 73-77. DOI: 10.7619/jcmp.20233646
shu

Effect of oral probiotics on intestinal microecology in patients with chronic heart failure

  • 1.

    Department of Geriatrics, the Second People's Hospital of Kunming of Yunnan Province, Kunming, Yunnan, 650000

  • 2.

    Department of Laboratory Medicine, the Second People's Hospital of Kunming of Yunnan Province, Kunming, Yunnan, 650000

  • 3.

    Female Psychiatric Department, Yunnan Mental Hospital, Kunming, Yunnan, 650000

  • 4.

    Department of Cardiovascular Medicine, the Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650000

More Information
  • Received Date: November 13, 2023
  • Revised Date: February 27, 2024
  • Available Online: May 14, 2024
    Graphical Abstract
    • Abstract
  • Objective 

    To investigate the effect of probiotics in patients with chronic heart failure (CHF) and its impact on intestinal microecology.

    Methods 

    A total of 112 patients with CHF were selected as research subjects and randomly divided into study group and control group, with 56 patients in each group. The control group received angiotensin-converting enzyme inhibitors (ACEI) combined with angiotensin Ⅱ receptor blockers (ARB) for treatment, while the study group received bifidobacterium viable capsules on the basis of treatment in the control group. The levels of myocardial fibrosis markers[type Ⅰ collagen precursor C-propeptide (PⅠCP), type Ⅲ collagen precursor N-propeptide (PⅢNP), PⅠCP/PⅢNP, type Ⅰ collagen carboxyl-terminal peptide (ⅠCTP)], cardiac function indicators[leftventricular ejection fraction (LVEF), left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter (LVESD), left ventricular end-systolic volume (LVESV)], intestinal flora abundance, plasma trimethylamine oxide (TMAO) levels, and serum tumor necrosis factor-α(TNF-α) and interleukin-1β(IL-1β) levels were measured in both groups. The therapeutic effects, drug safety, re-hospitalization rate, and mortality rate within 3 months after discharge were observed in both groups.

    Results 

    The total effective rate in the study group was 71.43 %, which was higher than 51.79 % in the control group (P < 0.05). After treatment, the LVEF in the study group was higher than that in the control group, while LVEDD, LVESD, and LVESV were lower than those in the control group (P < 0.05). After treatment, the PⅠCP/PⅢNP in the study group was higher than that in the control group, while the ⅠCTP level was lower than that in the control group (P < 0.05). After treatment, the abundances of Proteobacteria, Actinobacteria, Firmicutes, and Fusobacteria in the study group were lower than those in the control group, while the abundance of Bacteroidetes was higher than that in the control group (P < 0.05). After treatment, the levels of TMAO, TNF-α, and IL-1β in the study group were lower than those in the control group (P < 0.05). No serious adverse reactions occurred in either group after treatment. Within 3 months after discharge, the re-hospitalization rate in the study group was 12.50 %, which was lower than 30.36 %in the control group (P < 0.05). The mortality rates in the study group and the control group were 1.79 % and 7.14 %, respectively, but no statistically significant difference was observed(P>0.05).

    Conclusion 

    The combination of probiotics with ACEI and ARB can effectively reduce myocardial fibrosis in patients with CHF and improve intestinal microecology and prognosis.

    • FullText(HTML)
    • References (24)
  • [1]
    徐艳, 余敏, 王璐璐. 改良早期预警评分联合超声心动图及血清标志物预测老年慢性心力衰竭病人长期预后的临床价值[J]. 中西医结合心脑血管病杂志, 2022, 20(24): 4572-4576. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYY202224030.htm
    [2]
    MASCOLO A, MAURO G D, CAPPETTA D, et al. Current and future therapeutic perspective in chronic heart failure[J]. Pharmacol Res, 2022, 175: 106035. doi: 10.1016/j.phrs.2021.106035
    [3]
    潘东, 蒲丽君, 王伟, 等. 沙库巴曲缬沙坦与培哚普利对改善慢性心力衰竭患者心室重构的对比研究[J]. 实用临床医药杂志, 2021, 25(7): 93-97. doi: 10.7619/jcmp.20201469
    [4]
    MARTIN N, MANOHARAN K, THOMAS J, et al. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction[J]. Cochrane Database Syst Rev, 2018, 6(6): CD012721.
    [5]
    KSIAZCZYK M, LELONEK M. Angiotensin receptor/neprilysin inhibitor-a breakthrough in chronic heart failure therapy: summary of subanalysis on PARADIGM-HF trial findings[J]. Heart Fail Rev, 2020, 25(3): 393-402. doi: 10.1007/s10741-019-09879-x
    [6]
    罗特丹, 周冲冲, 黄鹤鸣. 肠内营养联合双歧杆菌三联活菌对老年慢性心力衰竭病人心功能及微炎症状态的影响[J]. 实用老年医学, 2022, 36(9): 883-887. https://www.cnki.com.cn/Article/CJFDTOTAL-SYLA202209005.htm
    [7]
    中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心力衰竭和心肌病杂志: 中英文, 2018, 2(4): 196-225. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYW201910003.htm
    [8]
    BREDY C, MINISTERI M, KEMPNY A, et al. New York Heart Association (NYHA) classification in adults with congenital heart disease: relation to objective measures of exercise and outcome[J]. Eur Heart J Qual Care Clin Outcomes, 2018, 4(1): 51-58. doi: 10.1093/ehjqcco/qcx031
    [9]
    郑筱萸. 中药新药临床研究指导原则: 试行[M]. 北京: 中国医药科技出版社, 2002: 68-73, 77-85.
    [10]
    任宝燕, 王绥绥. 早期心脏康复策略对急性心肌梗死PCI后患者心功能、日常生活能力的影响[J]. 临床医学研究与实践, 2023, 8(14): 178-181. https://www.cnki.com.cn/Article/CJFDTOTAL-YLYS202314051.htm
    [11]
    杨晓明, 郑祥, 王超超. 肠道菌群代谢产物与冠心病合并慢性心力衰竭的相关性及对患者预后水平的预测作用[J]. 中华全科医学, 2023, 21(10): 1676-1678, 1718. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202310011.htm
    [12]
    詹真皇, 周明君, 李重阳, 等. 慢性心力衰竭患者血清BNP、Copeptin水平与短期不良终点事件的关系[J]. 检验医学与临床, 2023, 20(10): 1447-1450. https://www.cnki.com.cn/Article/CJFDTOTAL-JYYL202310024.htm
    [13]
    徐欢欢, 薛莉. 沙库巴曲缬沙坦对射血分数保留心力衰竭的影响[J]. 宁夏医科大学学报, 2022, 44(10): 1024-1028. https://www.cnki.com.cn/Article/CJFDTOTAL-XNXY202210011.htm
    [14]
    翁菲菲, 冯文化, 郭青榜, 等. 老年慢性心力衰竭患者血清新型炎性因子水平与心室重构的关系[J]. 中国临床医生杂志, 2022, 50(3): 294-298. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLYS202203012.htm
    [15]
    张芳, 陈国藩, 任开涵, 等. 麝香保心丸对老年慢性心力衰竭患者心功能、心室重构及血管内皮因子的影响[J]. 中华全科医学, 2022, 20(12): 2006-2009. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202212004.htm
    [16]
    MARTÍNEZ-MILLA J, GARCÍA M C, URQUÍA M T, et al. Blockade of renin-angiotensin-aldosterone system in elderly patients with heart failure and chronic kidney disease: results of a single-center, observational cohort study[J]. Drugs Aging, 2019, 36(12): 1123-1131. doi: 10.1007/s40266-019-00709-1
    [17]
    张振东, 蔡斌, 王宏伟, 等. 肠道菌群及其代谢产物苯乙酰谷氨酰胺在慢性心力衰竭患者中的变化研究[J]. 中国全科医学, 2023, 26(29): 3665-3673. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX202329010.htm
    [18]
    邢团结, 娄焕堃, 李鹏, 等. 血清氧化三甲胺水平与冠心病及冠状动脉狭窄程度的相关性分析[J]. 蚌埠医学院学报, 2023, 48(4): 466-469, 473. https://www.cnki.com.cn/Article/CJFDTOTAL-BANG202304011.htm
    [19]
    MANSURI N M, MANN N K, RIZWAN S, et al. Role of gut microbiome in cardiovascular events: a systematic review[J]. Cureus, 2022, 14(12): e32465.
    [20]
    王亚楠, 李保. 肠道菌群及其代谢物氧化三甲胺与心肌梗死关系的研究进展[J]. 中西医结合心脑血管病杂志, 2021, 19(24): 4305-4308. doi: 10.12102/j.issn.1672-1349.2021.24.019
    [21]
    邵良发, 鄢高亮, 张启杰, 等. TMAO通过PI3K/Akt/mTOR通路干预急性心肌梗死病人动脉斑块的作用机制[J]. 中西医结合心脑血管病杂志, 2023, 21(8): 1427-1431, 1436. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYY202308012.htm
    [22]
    李泽桦, 曾宇宏, 冯丽芸, 等. 氧化三甲胺促进M1型巨噬细胞极化加剧心肌梗死后心室重构[J]. 实用医学杂志, 2022, 38(20): 2531-2537, 2544. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ202220005.htm
    [23]
    陈艳, 许丽丽, 王丽曼, 等. 血浆三甲胺N-氧化物与心肌梗死关系的研究进展[J]. 医药导报, 2023, 42(4): 524-528. https://www.cnki.com.cn/Article/CJFDTOTAL-YYDB202304013.htm
    [24]
    张月, 杨得振. 急性心肌梗死患者肠道菌群的变化[J]. 检验医学与临床, 2019, 16(14): 1978-1981. https://www.cnki.com.cn/Article/CJFDTOTAL-JYYL201914008.htm
    • Related Articles

  • Related Articles

    [1]ZHANG Shuyuan, HUANG Yongtao, YU Wenjin. Relationship between non-high-density lipoprotein cholesterol and cardiovascular disease in maintenance hemodialysis patients[J]. Journal of Clinical Medicine in Practice, 2025, 29(5): 106-111. DOI: 10.7619/jcmp.20244504
    [2]MAO Juncong, HONG Yunfei, WEI Yin, CAI Yerui, YIN Jinsong. Application values of triglyceride and glucose index, metabolic insulin resistance score and triglyceride to high-density lipoprotein cholesterol ratio in patients with acute coronary syndrome complicated with multivessel coronary artery disease[J]. Journal of Clinical Medicine in Practice, 2025, 29(5): 56-63. DOI: 10.7619/jcmp.20243599
    [3]LI Yanian, HE Shenghu. Research progress of triglyceride glucose-body mass index[J]. Journal of Clinical Medicine in Practice, 2022, 26(9): 130-133. DOI: 10.7619/jcmp.20213765
    [4]DENG Junjie, HU Jingxuan, LI Xinghua, LU Yao. Value of small dense low density lipoprotein cholesterol in predicting major adverse cardiovascular events of elderly patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2022, 26(3): 34-38. DOI: 10.7619/jcmp.20214401
    [5]QIU Xueting, WANG Min, WANG Zhixiao, YANG Tao, SUN Min. Relationship between high density lipoprotein cholesterol level and thyroid autoimmunity[J]. Journal of Clinical Medicine in Practice, 2021, 25(13): 1-4, 14. DOI: 10.7619/jcmp.20211491
    [6]CHEN Yuchi, LIU Qiang. Correlation between monocyte to high-density lipoprotein cholesterol ratio and carotid artery stenosis in patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 36-39. DOI: 10.7619/jcmp.20201217
    [7]JU Xiangli, PEI Dongmei. Relationship between 25 hydroxyvitamin D deficiency and abnormal blood lipid, overweight or obesity[J]. Journal of Clinical Medicine in Practice, 2020, 24(6): 101-104. DOI: 10.7619/jcmp.202006028
    [8]CHEN Jianbing, CHEN Yinuo, ZHUANG Xiao, FENG Panpan, YANG Fan, WANG Xiang, JI Yue′e, WANG Jinchun. Role of scutellaria baicalensis stem-leaf total flavonoid in regulating blood lipid level of rats with hypertriglyceridemia[J]. Journal of Clinical Medicine in Practice, 2019, 23(21): 70-73. DOI: 10.7619/jcmp.201921021
    [9]SUN Wenjing, HUANG Liuqing, ZHOU Fei, YANG Yang, WANG Huaying, XIE Tao, YOU Chunmei. Value of apolipoprotein B combined with low density lipoprotein cholesterol detection in the predication of acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2018, (21): 102-103,106. DOI: 10.7619/jcmp.201821031
    [10]ZHANG Guanzhuang. Correlations between cerebral hemorrhage transformation and total cholesterol, low density lipoprotein and high density lipoprotein[J]. Journal of Clinical Medicine in Practice, 2016, (11): 18-20. DOI: 10.7619/jcmp.201611006

  • Cited by

    Periodical cited type(10)

    1. 赵婷婷，韩玮. 针对性护理对慢性胃溃疡合并高血压患者的效果观察. 贵州医药. 2024(02): 304-305 .
    2. 洪丹妮，叶艳. 电子病床倾斜角度对消化内科患者舒适度的影响. 医疗装备. 2024(05): 118-120 .
    3. 杨照平. 云南白药辅治脑出血后应激性胃溃疡临床观察. 实用中医药杂志. 2024(06): 1096-1099 .
    4. 段小兵，王国涛，王冠军，胡国超. 血清高迁移率族蛋白Bl、白细胞介素-6与高血压性脑出血患者神经内镜微创术后神经功能及预后的关系. 成都医学院学报. 2024(04): 674-678 .
    5. 王攀，曾群. 中老年女性脑出血患者合并胃肠功能紊乱的多因素分析预测模型构建. 中国妇幼保健. 2024(20): 4045-4048 .
    6. 刘春军，严方方，杨哲，王宝锋. 瑞巴派特联合莫沙必利治疗应激性胃溃疡的效果分析. 中国实用医刊. 2024(23): 91-93 .
    7. 徐微，林小花，刘媛，何雪云，徐建光. 甘海胃康胶囊联合西药治疗气滞型老年胃溃疡临床研究. 新中医. 2023(17): 112-116 .
    8. 王磊，夏岩，张灯亮. 高血压脑出血患者术后出现消化道应激性溃疡出血的影响因素分析. 现代医学. 2023(10): 1464-1469 .
    9. 巩丹丹，马兴好. 高能量密度肠内营养支持对应激性胃溃疡患者胃粘膜修复的影响. 中国食物与营养. 2022(08): 53-56+62 .
    10. 田永建，姜伟峰，刘芳. 消化内镜联合瑞巴派特在胃溃疡出血中应用价值分析. 疾病监测与控制. 2022(05): 383-386 .

    Other cited types(1)

Catalog

    Get Citation
    PDF
    XML
    Article views (134) PDF downloads (9) Cited by(11)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return